See what our work changed for clients
96%
From: Demand-based forecasting for multi-channel distribution
30%
From: AI-powered indication prioritization in oncology
18 → 6
From: Biotech investment strategy in an uncertain market
6–9 mo
From: Gene therapy patient funnel across 15 countries
Building a Global Patient Funnel to Predict Uptake for a Gene Therapy Across 15 Countries
Home / Case Studies / Building a Global Patient Funnel to Predict Uptake for a Gene Therapy Across 15 Countries Case Studies Building a Global Patient Funnel to Predict Uptake for a Gene Therapy Across 15 Countries 4 min read Get the Detailed PDF The…
Find work like yours
Home / Case Studies / Building a Global Patient Funnel to Predict Uptake for a Gene Therapy Across 15 Countries Case Studies Building a Global
The protein was named for the wrong job. In 1992, Tasuku Honjo’s group at Kyoto University was hunting for genes tied to cell death in
Patients with severe Gorlin syndrome can face repeated surgeries year after year, many of them on the face. Each one can leave a scar, and
Rare disease markets have an odd commercial paradox built into them: the patient population is tiny, but the market opportunity can still be substantial. That’s
For years, chemotherapy was the backbone of triple-negative breast cancer (TNBC) treatment because the disease lacked the molecular targets that transformed treatment in other breast
Every drug development program starts with a hypothesis about the product it hopes to become. The Target Product Profile (TPP) is where that hypothesis is
Tell us what you're trying to solve
Get the full story in your inbox
- Report & Insights
- Strategy Products
Strategy Products
- Consulting Services
- Media
Media
